Gkika, E.; Grosu, A.-L.; Macarulla Mercade, T.; Cubillo Gracián, A.; Brunner, T.B.; Schultheiß, M.; Pazgan-Simon, M.; Seufferlein, T.; Touchefeu, Y.
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study. Cancers 2022, 14, 1568.
https://doi.org/10.3390/cancers14061568
AMA Style
Gkika E, Grosu A-L, Macarulla Mercade T, Cubillo Gracián A, Brunner TB, Schultheiß M, Pazgan-Simon M, Seufferlein T, Touchefeu Y.
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study. Cancers. 2022; 14(6):1568.
https://doi.org/10.3390/cancers14061568
Chicago/Turabian Style
Gkika, Eleni, Anca-Ligia Grosu, Teresa Macarulla Mercade, Antonio Cubillo Gracián, Thomas B. Brunner, Michael Schultheiß, Monika Pazgan-Simon, Thomas Seufferlein, and Yann Touchefeu.
2022. "Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study" Cancers 14, no. 6: 1568.
https://doi.org/10.3390/cancers14061568
APA Style
Gkika, E., Grosu, A. -L., Macarulla Mercade, T., Cubillo Gracián, A., Brunner, T. B., Schultheiß, M., Pazgan-Simon, M., Seufferlein, T., & Touchefeu, Y.
(2022). Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study. Cancers, 14(6), 1568.
https://doi.org/10.3390/cancers14061568